Read + Share
Shani H, Bernstein-Molho R, Laitman Y, Netzer I, et al. Double heterozygosity for TP53 and BRCA1 mutations: clinical implications in
populations with founder mutations. Breast Cancer Res Treat 2021;186:259-263.
PMID: 33449224
|
 |
|
Shani H, Bernstein-Molho R, Laitman Y, Netzer I, et al. Double heterozygosity for TP53 and BRCA1 mutations: clinical implications in
populations with founder mutations. Breast Cancer Res Treat 2021;186:259-263.
PMID: 33449224
|
|
|
|